ZAGREB (Croatia), August 10 (SeeNews) – Croatian blue-chip drug maker Pliva reported on Friday a surge in first-half net profit to 1.115 billion kuna ($209 million/153 million euro) from 370 million a year ago, positively affected by the transfer of its U.S. business to partner company, U.S. pharmaceuticals producer Barr.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
